Citation tools
"177Lu-FAP-2286 in patients with advanced or metastatic solid tumors: Initial data from a phase 1/2 study investigating safety, pharmacokinetics, dosimetry, and preliminary antitumor activity (LuMIERE)." Journal of Nuclear Medicine
63.supplement 2
(2022):
2271.
Web. 22 May. 2025.